Atlas Trials

A Study of Regorafenib in Advanced Pancreatic Cancer Patients

Clinical trial NCT02080260 · COMPLETED

Trial details

NCT number
NCT02080260
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2014-06-06
Primary completion
2017-06-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.